Explore Dual-PhD carrier research, patent-pending modified-chitosan delivery, and 4 flexible cosmetic ODM tracks.
Acetyl Hexapeptide-8 Wrinkle Care Serum Concept
A peptide-based serum concept built around Acetyl Hexapeptide-8, commonly used in wrinkle care and expression-line focused formulation projects. Suitable for internal evaluation, concept validation, and OEM/ODM development discussions.
Formulation Snapshot
Formulation Snapshot
+219% 8-hour ex-vivo skin permeation, -32.0% ACh inhibition at 1/10th dose, and GQI 33-subject trial data.
Inspect on-site booth photos, ISO 22716:2007 cosmetic GMP certificate, and buyer Q&A from Guangzhou.
Applications
Application Direction
- Wrinkle care serum
- Expression-line care
- Peptide skincare
- Active serum concept
Overview
Overview
This formulation concept is designed for teams evaluating peptide-based serum development for wrinkle care and expression-line focused skincare projects. It provides a structured starting point for early product planning built around Acetyl Hexapeptide-8.
Details
Details
Important Note: This page presents a reference formulation concept for evaluation, OEM/ODM discussion, and product development planning. It is not presented as a retail-ready finished product or a final regulatory-approved market formula.
Concept Positioning
Acetyl Hexapeptide-8 is commonly reviewed in skincare projects focused on wrinkle care, expression-line positioning, and lightweight active serum development. This concept provides a practical reference for teams exploring peptide-based serum formats in a commercially relevant structure.
Typical Product Direction
- Wrinkle care serum concepts
- Expression-line focused skincare projects
- Daily active serum development
- Peptide-led anti-aging product planning
Why Teams Review This Concept
- Evaluate how Acetyl Hexapeptide-8 fits into a serum format
- Build internal concept alignment before formal formulation work
- Support discussions with OEM/ODM partners on texture and positioning
- Shorten early-stage product planning and validation steps
What Can Be Discussed
- Peptide concentration direction
- Serum texture and application positioning
- Supporting ingredient system
- Documentation package for internal review
- Project customization for target markets
Development Notes
Final formulation, compatibility, stability, claims language, and compliance requirements should be confirmed during the actual product development process.
Development Discussion Guide
Development Discussion Guide
Project Brief
Use this section to confirm target format, target market, and the desired wrinkle care positioning before moving deeper into OEM / ODM follow-up.
Technical Alignment
Review the key peptide, supporting file needs, and any sample or validation expectations that should be aligned for the next discussion step.
Customization Scope
Clarify whether the project needs formula adjustment, texture direction, packaging discussion, or staged development planning before scale-up.
FAQ
Frequently Asked Questions
Can you support sample planning and follow-up toward larger-scale production?
That can be discussed according to the project scope and current stage. For finished-product projects, it is helpful to first clarify the product direction, expected development path, and what kind of evaluation your team needs next.
Cosmetic Pro-Peptide Delivery & Flexible ISO 22716 ODM
Developing a mid-to-high-end skincare or scalp SKU with Acetyl Hexapeptide-8 Wrinkle Care Serum Concept?
Compare neat raw actives, AHPX+ modified-chitosan delivery complex
(CN120248173A, +219% 8h skin permeation), bulk compounded
kg / liter semi-finished bases, and phased custom-packaged ODM at
Suzhou Xilin Technology Co., Ltd. (ISO 22716:2007 Cert. 27825-2025GPOC00009R000,
covering liquid & eye-care/cream scope): explore our Pro-Peptide Science & ODM Hub or Finished Skincare OEM / ODM Service.
Request Acetyl Hexapeptide-8 Wrinkle Care Serum Concept Benchmark Sample, Bulk Base, or Phased ODM Quote
Share your target format (raw active by g/kg, bulk semi-finished base by kg/liter, or custom-packaged ODM), target active %, and destination market (EU PIF/CPSR, UK SCPN, US MoCRA, ANVISA).